Heterocephalus glaber (naked mole-rat): 101718432
Help
Entry
101718432 CDS
T02812
Symbol
Tnf
Name
(RefSeq) tumor necrosis factor
KO
K03156
tumor necrosis factor superfamily, member 2
Organism
hgl
Heterocephalus glaber (naked mole-rat)
Pathway
hgl01523
Antifolate resistance
hgl04010
MAPK signaling pathway
hgl04060
Cytokine-cytokine receptor interaction
hgl04061
Viral protein interaction with cytokine and cytokine receptor
hgl04064
NF-kappa B signaling pathway
hgl04071
Sphingolipid signaling pathway
hgl04150
mTOR signaling pathway
hgl04210
Apoptosis
hgl04217
Necroptosis
hgl04350
TGF-beta signaling pathway
hgl04380
Osteoclast differentiation
hgl04612
Antigen processing and presentation
hgl04620
Toll-like receptor signaling pathway
hgl04621
NOD-like receptor signaling pathway
hgl04622
RIG-I-like receptor signaling pathway
hgl04625
C-type lectin receptor signaling pathway
hgl04640
Hematopoietic cell lineage
hgl04650
Natural killer cell mediated cytotoxicity
hgl04657
IL-17 signaling pathway
hgl04660
T cell receptor signaling pathway
hgl04664
Fc epsilon RI signaling pathway
hgl04668
TNF signaling pathway
hgl04920
Adipocytokine signaling pathway
hgl04930
Type II diabetes mellitus
hgl04931
Insulin resistance
hgl04932
Non-alcoholic fatty liver disease
hgl04933
AGE-RAGE signaling pathway in diabetic complications
hgl04936
Alcoholic liver disease
hgl04940
Type I diabetes mellitus
hgl05010
Alzheimer disease
hgl05014
Amyotrophic lateral sclerosis
hgl05020
Prion disease
hgl05022
Pathways of neurodegeneration - multiple diseases
hgl05132
Salmonella infection
hgl05133
Pertussis
hgl05134
Legionellosis
hgl05135
Yersinia infection
hgl05140
Leishmaniasis
hgl05142
Chagas disease
hgl05143
African trypanosomiasis
hgl05144
Malaria
hgl05145
Toxoplasmosis
hgl05146
Amoebiasis
hgl05152
Tuberculosis
hgl05160
Hepatitis C
hgl05161
Hepatitis B
hgl05163
Human cytomegalovirus infection
hgl05164
Influenza A
hgl05165
Human papillomavirus infection
hgl05166
Human T-cell leukemia virus 1 infection
hgl05168
Herpes simplex virus 1 infection
hgl05169
Epstein-Barr virus infection
hgl05170
Human immunodeficiency virus 1 infection
hgl05171
Coronavirus disease - COVID-19
hgl05205
Proteoglycans in cancer
hgl05310
Asthma
hgl05321
Inflammatory bowel disease
hgl05322
Systemic lupus erythematosus
hgl05323
Rheumatoid arthritis
hgl05330
Allograft rejection
hgl05332
Graft-versus-host disease
hgl05410
Hypertrophic cardiomyopathy
hgl05414
Dilated cardiomyopathy
hgl05417
Lipid and atherosclerosis
hgl05418
Fluid shear stress and atherosclerosis
Brite
KEGG Orthology (KO) [BR:
hgl00001
]
09130 Environmental Information Processing
09132 Signal transduction
04010 MAPK signaling pathway
101718432 (Tnf)
04350 TGF-beta signaling pathway
101718432 (Tnf)
04064 NF-kappa B signaling pathway
101718432 (Tnf)
04668 TNF signaling pathway
101718432 (Tnf)
04071 Sphingolipid signaling pathway
101718432 (Tnf)
04150 mTOR signaling pathway
101718432 (Tnf)
09133 Signaling molecules and interaction
04060 Cytokine-cytokine receptor interaction
101718432 (Tnf)
04061 Viral protein interaction with cytokine and cytokine receptor
101718432 (Tnf)
09140 Cellular Processes
09143 Cell growth and death
04210 Apoptosis
101718432 (Tnf)
04217 Necroptosis
101718432 (Tnf)
09150 Organismal Systems
09151 Immune system
04640 Hematopoietic cell lineage
101718432 (Tnf)
04620 Toll-like receptor signaling pathway
101718432 (Tnf)
04621 NOD-like receptor signaling pathway
101718432 (Tnf)
04622 RIG-I-like receptor signaling pathway
101718432 (Tnf)
04625 C-type lectin receptor signaling pathway
101718432 (Tnf)
04650 Natural killer cell mediated cytotoxicity
101718432 (Tnf)
04612 Antigen processing and presentation
101718432 (Tnf)
04660 T cell receptor signaling pathway
101718432 (Tnf)
04657 IL-17 signaling pathway
101718432 (Tnf)
04664 Fc epsilon RI signaling pathway
101718432 (Tnf)
09152 Endocrine system
04920 Adipocytokine signaling pathway
101718432 (Tnf)
09158 Development and regeneration
04380 Osteoclast differentiation
101718432 (Tnf)
09160 Human Diseases
09161 Cancer: overview
05205 Proteoglycans in cancer
101718432 (Tnf)
09172 Infectious disease: viral
05166 Human T-cell leukemia virus 1 infection
101718432 (Tnf)
05170 Human immunodeficiency virus 1 infection
101718432 (Tnf)
05161 Hepatitis B
101718432 (Tnf)
05160 Hepatitis C
101718432 (Tnf)
05171 Coronavirus disease - COVID-19
101718432 (Tnf)
05164 Influenza A
101718432 (Tnf)
05168 Herpes simplex virus 1 infection
101718432 (Tnf)
05163 Human cytomegalovirus infection
101718432 (Tnf)
05169 Epstein-Barr virus infection
101718432 (Tnf)
05165 Human papillomavirus infection
101718432 (Tnf)
09171 Infectious disease: bacterial
05132 Salmonella infection
101718432 (Tnf)
05135 Yersinia infection
101718432 (Tnf)
05133 Pertussis
101718432 (Tnf)
05134 Legionellosis
101718432 (Tnf)
05152 Tuberculosis
101718432 (Tnf)
09174 Infectious disease: parasitic
05146 Amoebiasis
101718432 (Tnf)
05144 Malaria
101718432 (Tnf)
05145 Toxoplasmosis
101718432 (Tnf)
05140 Leishmaniasis
101718432 (Tnf)
05142 Chagas disease
101718432 (Tnf)
05143 African trypanosomiasis
101718432 (Tnf)
09163 Immune disease
05310 Asthma
101718432 (Tnf)
05322 Systemic lupus erythematosus
101718432 (Tnf)
05323 Rheumatoid arthritis
101718432 (Tnf)
05321 Inflammatory bowel disease
101718432 (Tnf)
05330 Allograft rejection
101718432 (Tnf)
05332 Graft-versus-host disease
101718432 (Tnf)
09164 Neurodegenerative disease
05010 Alzheimer disease
101718432 (Tnf)
05014 Amyotrophic lateral sclerosis
101718432 (Tnf)
05020 Prion disease
101718432 (Tnf)
05022 Pathways of neurodegeneration - multiple diseases
101718432 (Tnf)
09166 Cardiovascular disease
05417 Lipid and atherosclerosis
101718432 (Tnf)
05418 Fluid shear stress and atherosclerosis
101718432 (Tnf)
05410 Hypertrophic cardiomyopathy
101718432 (Tnf)
05414 Dilated cardiomyopathy
101718432 (Tnf)
09167 Endocrine and metabolic disease
04930 Type II diabetes mellitus
101718432 (Tnf)
04940 Type I diabetes mellitus
101718432 (Tnf)
04936 Alcoholic liver disease
101718432 (Tnf)
04932 Non-alcoholic fatty liver disease
101718432 (Tnf)
04931 Insulin resistance
101718432 (Tnf)
04933 AGE-RAGE signaling pathway in diabetic complications
101718432 (Tnf)
09176 Drug resistance: antineoplastic
01523 Antifolate resistance
101718432 (Tnf)
09180 Brite Hierarchies
09183 Protein families: signaling and cellular processes
04052 Cytokines and neuropeptides [BR:
hgl04052
]
101718432 (Tnf)
00536 Glycosaminoglycan binding proteins [BR:
hgl00536
]
101718432 (Tnf)
Cytokines and neuropeptides [BR:
hgl04052
]
Cytokines
Tumor necrosis fators
101718432 (Tnf)
Glycosaminoglycan binding proteins [BR:
hgl00536
]
Heparan sulfate / Heparin
Cytokines
101718432 (Tnf)
BRITE hierarchy
SSDB
Ortholog
Paralog
GFIT
Motif
Pfam:
TNF
PD-C2-AF1
Motif
Other DBs
NCBI-GeneID:
101718432
NCBI-ProteinID:
XP_004847074
UniProt:
G5C3E2
LinkDB
All DBs
Position
Un
AA seq
230 aa
AA seq
DB search
MSTESMIRDVELAGEEPLQKAGGPQGSGRCWCLSFFSFLLVAGATTLFCLLHFGVIGPQR
GEFKDLNFFSPLFSTGSASQSGNDKPVAHVVANQQGQEKLEWLSKRANALLANGMDLTDN
QLVVPSDGLYLVYSQVLFKGQGCPSYVLLTHTVSRLAISYQDKVNLLSAIKSPCQKETPE
GAELKPWYEPVYLGGVFQLQKGDRLSAEVNLPDYLDFAESGQIYFGAIAL
NT seq
693 nt
NT seq
+upstream
nt +downstream
nt
atgagcacagaaagcatgatccgggacgtggagctcgctggggaggagcccctccagaag
gcagggggcccccagggctccgggcggtgctggtgcctcagcttcttctccttcctgctc
gtggcaggagccaccacgctcttctgcctgctgcacttcggggtgatcggcccccagcgg
ggagagtttaaggatctcaactttttctctcctctgttctccacaggatcagcttctcaa
agcgggaatgacaagcctgttgctcatgttgtagcaaaccaacaaggacaggagaagctg
gagtggctgagcaagcgtgccaatgccctcttggccaatggcatggatctaacggacaac
cagctggtggtgccttcggacgggctgtacctcgtctactcccaggtcctcttcaagggc
caaggctgcccctcctacgtcctcctcacccatactgtcagccgcctagccatctcctac
caggacaaggtcaacctcctgtctgccatcaagagtccctgccagaaggagaccccagag
ggggctgagctcaagccctggtatgagcccgtctacctgggaggggtcttccagctgcag
aagggagaccgcctcagtgccgaggtcaatctgcccgactatcttgacttcgcggagtcc
gggcagatctacttcggggccattgccctgtga
DBGET
integrated database retrieval system